These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31008951)

  • 21. Emergency Department Discharge of Pulmonary Embolus Patients.
    Frank Peacock W; Coleman CI; Diercks DB; Francis S; Kabrhel C; Keay C; Kline JA; Manteuffel J; Wildgoose P; Xiang J; Singer AJ
    Acad Emerg Med; 2018 Sep; 25(9):995-1003. PubMed ID: 29757489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.
    Barco S; Schmidtmann I; Ageno W; Bauersachs RM; Becattini C; Bernardi E; Beyer-Westendorf J; Bonacchini L; Brachmann J; Christ M; Czihal M; Duerschmied D; Empen K; Espinola-Klein C; Ficker JH; Fonseca C; Genth-Zotz S; Jiménez D; Harjola VP; Held M; Iogna Prat L; Lange TJ; Manolis A; Meyer A; Mustonen P; Rauch-Kroehnert U; Ruiz-Artacho P; Schellong S; Schwaiblmair M; Stahrenberg R; Westerweel PE; Wild PS; Konstantinides SV; Lankeit M;
    Eur Heart J; 2020 Jan; 41(4):509-518. PubMed ID: 31120118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant data.
    Robin P; Eddy M; Sikora L; Le Roux PY; Carrier M; Couturaud F; Planquette B; Pesavento R; Rodger M; Salaun PY; Le Gal G
    BMJ Open; 2018 Nov; 8(11):e023939. PubMed ID: 30498046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of Chinese medicines for vitreous hemorrhage: A protocol for systematic review and meta-analysis.
    Han M; Liu Z; Nong L; Zi Y; Meng H; Deng Y; Wang ZJ; Jin M
    Medicine (Baltimore); 2020 May; 99(19):e20086. PubMed ID: 32384479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial.
    Yhim HY; Choi WI; Kim SH; Nam SH; Kim KH; Mun YC; Oh D; Hwang HG; Lee KW; Song EK; Kwon YS; Bang SM
    Korean J Intern Med; 2019 Sep; 34(5):1125-1135. PubMed ID: 29788694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter Trial of Rivaroxaban for Early Discharge of Pulmonary Embolism From the Emergency Department (MERCURY PE): Rationale and Design.
    Singer AJ; Xiang J; Kabrhel C; Merli GJ; Pollack C; Tapson VF; Wildgoose P; Peacock WF
    Acad Emerg Med; 2016 Nov; 23(11):1280-1286. PubMed ID: 27537530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outpatient versus inpatient treatment for acute pulmonary embolism.
    Yoo HH; Nunes-Nogueira VS; Fortes Villas Boas PJ; Broderick C
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD010019. PubMed ID: 30839095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Phase IV Study of Thromboembolic and Bleeding Events Following Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor.
    Gomez D; Razmjou H; Donovan A; Bansal VB; Gollish JD; Murnaghan JJ
    J Arthroplasty; 2017 Mar; 32(3):958-964. PubMed ID: 27843040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A treatment strategy using subcutaneous fondaparinux followed by oral rivaroxaban is effective for treating acute venous thromboembolism.
    Kabuki T; Nakanishi R; Hisatake S; Fujii T; Dobashi S; Wakakura S; Kiuchi S; Fujino T; Ikeda T
    J Cardiol; 2017 Aug; 70(2):163-168. PubMed ID: 27979674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of efficacy and safety of rivaroxaban combined with aspirin in patients with chronic coronary artery disease: A protocol for systematic review and meta-analysis.
    Wang H; Li X; Wu X; Wu H; Xie G; Wang H
    Medicine (Baltimore); 2022 Feb; 101(6):e28779. PubMed ID: 35147105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute pulmonary embolism treatment with rivaroxaban results in a shorter duration of hospitalisation compared to standard therapy: an academic centre experience.
    Paczyńska M; Kurnicka K; Lichodziejewska B; Goliszek S; Dzikowska-Diduch O; Sobieraj P; Burzyński Ł; Kostrubiec M; Pruszczyk P; Ciurzyński M
    Kardiol Pol; 2016; 74(7):650-6. PubMed ID: 26779849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Herbal medicine on cancer-related fatigue of lung cancer survivors: Protocol for a systematic review.
    Kwon CY; Lee B; Kim KI; Lee BJ
    Medicine (Baltimore); 2020 Jan; 99(5):e18968. PubMed ID: 32000424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multidisciplinary approach to the management of patients with pulmonary embolism and deep vein thrombosis: a consensus on diagnosis, traditional therapy and therapy with rivaroxaban.
    Imberti D; Becattini C; Bernardi E; Camporese G; Cuccia C; Dentali F; Paretti D
    Intern Emerg Med; 2018 Oct; 13(7):1037-1049. PubMed ID: 29520700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes associated with observation status versus inpatient management of pulmonary embolism patients anticoagulated with rivaroxaban.
    Weeda ER; Wells PS; Peacock WF; Fermann GJ; Baugh CW; Ashton V; Crivera C; Wildgoose P; Schein JR; Coleman CI
    Int J Cardiol; 2016 Nov; 222():846-849. PubMed ID: 27522388
    [No Abstract]   [Full Text] [Related]  

  • 35. Best evidence topic reports. BET 1: is long-term Rivaroxaban superior to Warfarin in pulmonary embolism?
    Morgan C; Body R
    Emerg Med J; 2015 Nov; 32(11):895-8. PubMed ID: 26490283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rivaroxaban for the treatment of venous thromboembolism in real life: A single-center prospective study.
    Demelo-Rodríguez P; Galeano-Valle F; García-Fernández-Bravo I; Piqueras-Ruiz S; Álvarez-Sala-Walther L; Del Toro-Cervera J
    Medicine (Baltimore); 2019 Jan; 98(3):e14093. PubMed ID: 30653127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omega-3 and ranibizumab for age-related macular degeneration: A systematic review protocol.
    Meng Y; Liu HW; Sun P; Zhou PP; Wang JJ
    Medicine (Baltimore); 2019 Mar; 98(13):e14516. PubMed ID: 30921177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of inhibitors of factor Xa for the treatment of pulmonary embolism.
    Prandoni P; Temraz S; Barbar S; Pesavento R; Taher A
    Intern Emerg Med; 2014 Sep; 9(6):617-22. PubMed ID: 24871638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension.
    Wells PS; Prins MH; Levitan B; Beyer-Westendorf J; Brighton TA; Bounameaux H; Cohen AT; Davidson BL; Prandoni P; Raskob GE; Yuan Z; Katz EG; Gebel M; Lensing AWA
    Chest; 2016 Nov; 150(5):1059-1068. PubMed ID: 27262225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acupotomy for the treatment of lumbar spinal stenosis: A protocol for a systematic review and meta-analysis.
    Kwon CY; Yoon SH; Lee B; Leem J
    Medicine (Baltimore); 2019 Jan; 98(3):e14160. PubMed ID: 30653158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.